Search Results for: als

Summary of George Daley talk on iPS cells today in Seattle

The best talk today was the keynote address by Dr. George Daley focused mostly on iPS cells. Dr. Daley is one of the world’s experts on iPS cells and pluripotent stem cells more generally. He covered many interesting elements of the iPS cell field including the genetic mutations that seem to occur during the reprogramming

Summary of George Daley talk on iPS cells today in Seattle Read More »

Why invest in stem cells? Progress, Patients, and Patents

Why invest in stem cells? Ideas are the foundation of stem cell research, but funding makes those ideas a reality. We talk a lot about governmental funding of stem cell research through CIRM and NIH. The funding from these agencies is essential and will undoubtedly lead to new treatments and cures, possibly for millions of

Why invest in stem cells? Progress, Patients, and Patents Read More »

Why miRNA iPS cells might be the ticket: an A+ paper

Since Yamanaka’s discovery of iPS cells first in mouse and then in human cells 5 years ago, both made using viral transduction, a host of new methods to make iPS cells have been reported.  These methods are quite diverse, ranging from transposons, to recombinant proteins, to plasmids, and to RNA.  Often times these new approaches

Why miRNA iPS cells might be the ticket: an A+ paper Read More »

CIRM funds $25 million for Geron trial, $38 million for basic biology

Geron-300x2212

CIRM announced two sets of awards today that both should make major impact including its first clinical trial via Geron and $38 million for 27 basic biology studies. First Clinical Trial. Today CIRM awarded $25 million to support Geron’s FDA-approved clinical trial for spinal cord injury. This is CIRM’s first award to a for-profit company

CIRM funds $25 million for Geron trial, $38 million for basic biology Read More »